Interaction between the MTHFR C677T polymorphism and alcohol-impact on oral cancer risk and multiple DNA methylation of tumor-related genes

Journal of Dental Research

Volumn 90, Issue 1, 2011, Pages 65-70

  Supic, G ^a   Jovic, N ^a   Kozomara, R ^a   Zeljic, K ^a   Magic, Z ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

alcohol and MTHFR polymorphism; multiple DNA methylation; oral cancer risk

Indexed keywords

CADHERIN; CYTOSINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); RASSF1 PROTEIN, HUMAN; REPRESSOR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; THYMINE; TUMOR SUPPRESSOR PROTEIN; WIF1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; DNA METHYLATION; DRINKING BEHAVIOR; DRUG EFFECT; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MOUTH TUMOR; ONCOGENE; PATHOLOGY; RISK FACTOR; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CADHERINS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOSINE; DNA METHYLATION; FEMALE; GENES, P16; GENOTYPE; HUMANS; LYMPHATIC METASTASIS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; ONCOGENES; POLYMORPHISM, GENETIC; REPRESSOR PROTEINS; RISK FACTORS; SEX FACTORS; SMOKING; THYMINE; TUMOR SUPPRESSOR PROTEINS;

EID: 78650979029     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510385243     Document Type: Article

References (32)

1. Barros SP, Offenbacher S. (2009). Epigenetics: connecting environment and genotype to phenotype and disease. J Dent Res 88: 400-408.
2. Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, et al. (2002). Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res 62: 2370-2377.
3. Cai DW, Liu XF, Bu RG, Chen XN, Ning L., Cheng Y., et al. (2009). Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese population. J Int Med Res 37: 1882-1889.
4. Choi S., Myers JN (2008). Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res 87: 14-32 ; erratum in J Dent Res 87: 191, 2008.
5. Corn PG, Smith BD, Ruckdeschel ES, Douglas D., Baylin SB, Herman JG (2000). E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia. Clin Cancer Res 6: 4243-4248.
6. De Schutter H., Spaepen M., Van Opstal S., Vander Poorten V., Verbeken E., Nuyts S. (2009). The prevalence of microsatellite instability in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 135: 485-490.
7. De Vogel S., Wouters KA, Gottschalk RW, van Schooten FJ, de Goeij JF, de Bruïne AP, et al. (2009). Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiol Biomarkers Prev 18: 3086-3096.
8. Forastiere A., Koch W., Trotti A., Sidransky D. (2001). Head and neck cancer. N Engl J Med 345: 1890-1900 ; erratum in N Engl J Med 346: 788, 2002.
9. Friso S., Choi SW, Girelli D., Mason JB, Bagley PJ, Olivieri O., et al. (2002). A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99: 5606-5611.
10. Frosst P., Blom H., Milos R., Goyette P., Sheppard CA, Matthews RG, et al. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113.
11. Guo M., Ren J., House M., Qi Y., Brock M., Herman J. (2006). Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res 12: 4515-4522.
12. Herman J., Baylin S. (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054. (Pubitemid 37448928)
13. Herman J., Graff J., Myohanen S., Nelkin B., Baylin S. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826.
14. Karpinski P., Myszka A., Ramsey D., Misiak B., Gil J., Sebzda T., et al. (2010). Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev 34: 338-344.
15. Licchesi J., Westra W., Hooker C., Machida E., Baylin S., Herman J. (2008). Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. Carcinogenesis 29: 895-904.
16. Marsit CJ, Houseman EA, Christensen BC, Eddy K., Bueno R., Sugarbaker DJ, et al. (2006). Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res 66: 10621-10629.
17. Neumann AS, Lyons HJ, Shen H., Liu Z., Shi Q., Sturgis EM, et al. (2005). Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer 115: 131-136. (Pubitemid 40559678)
18. Palmisano W., Divine K., Saccomanno G., Gilliland FB, Baylin SB, Herman JG, et al. (2000). Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60: 5954-5958.
19. Petti S., Scully C. (2005). Oral cancer: the association between nation-based alcohol-drinking profiles and oral cancer mortality. Oral Oncol 41: 828-834.
20. Puri SK, Si L., Fan CY, Hanna E. (2005). Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 26: 12-17.
21. Shaw R. (2006). The epigenetics of oral cancer. Int J Oral Maxillofac Surg 35: 101-108.
22. Shaw R., Hall G., Lowe D., Bowers NL, Field JK, Risk JM, et al. (2007). CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology. Oral Oncol 43: 878-886.
23. Solomon P., Selvam G., Shanmugam G. (2008). Polymorphism in ADH and MTHFR genes in oral squamous cell carcinoma of Indians. Oral Diseases 14: 633-639.
24. Supic G., Kozomara R., Brankovic-Magic M., Jovic N., Magic Z. (2009). Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients. Oral Oncol 45: 1051-1057.
25. Suzuki T., Matsuo K., Hasegawa Y., Hiraki A., Wakai K., Hirose K., et al. (2007). One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci 98: 1439-1446. (Pubitemid 47241768)
26. Tanemura A., Terando AM, Sim MS, van Hoesel AQ, de Maat MF, Morton DL, et al. (2009). CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 15: 1801-1807.
27. Vairaktaris E., Yapijakis C., Kessler P., Vylliotis A., Ries J., Wiltfang J., et al. (2006). Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 132: 219-222. (Pubitemid 43144257)
28. Vaissiere T., Hung R., Zaridze D., Fasolo V., Ferro G., Tost J., et al. (2009). Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 69: 243-252.
29. van Engeland M., Weijenberg M., Roemen G., Brink M., Baylin SB, Herman JG, et al. (2003). Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: The Netherlands Cohort Study on Diet and Cancer. Cancer Res 63: 3133-3137.
30. Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI (1997). Diet and prostate cancer: a case-control study. Eur J Cancer 33: 101-107.
31. Wang J., Sasco A., Fu C., Xue H., Guo G., Hua Z., et al. (2008). Aberrant DNA methylation of p16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 17: 118-125.
32. Weinstein S., Gridley G., Harty L., Diehl SR, Brown LM, Winn DM, et al. (2002). Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. J Nutr 132: 762-767.